title: Rhinocerebral zygomycosis and subsequent treatment decisions in a young patient with AML.
authors.forename: Malte
authors.initials: M
authors.lastname: von Bonin
authors.forename: Kristina
authors.initials: K
authors.lastname: Hochauf
authors.forename: Stefan
authors.initials: S
authors.lastname: Monecke
authors.forename: Jörgen
authors.initials: J
authors.lastname: Radke
authors.forename: Christian
authors.initials: C
authors.lastname: Thiede
authors.forename: Martin
authors.initials: M
authors.lastname: Bornhäuser
authors.forename: Uwe
authors.initials: U
authors.lastname: Platzbecker
authors.forename: Gerhard
authors.initials: G
authors.lastname: Ehninger
authors.forename: Thomas
authors.initials: T
authors.lastname: Illmer
mesh_terms: D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use; D001927:Brain Diseases / Q000382:microbiology / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D015353:Eye Enucleation; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000150:complications* / Q000188:drug therapy; D008279:Magnetic Resonance Imaging; D008443:Maxillary Sinus; D013517:Otorhinolaryngologic Surgical Procedures; D010254:Paranasal Sinus Diseases / Q000382:microbiology / Q000473:pathology / Q000628:therapy*; D016896:Treatment Outcome; D020096:Zygomycosis / Q000382:microbiology / Q000473:pathology / Q000628:therapy*
chemical_list: D000935:Antifungal Agents